Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

5.37
-0.0400-0.74%
Post-market: 5.30-0.0692-1.29%17:12 EDT
Volume:772.12K
Turnover:4.20M
Market Cap:367.42M
PE:-2.76
High:5.66
Open:5.35
Low:5.27
Close:5.41
Loading ...

Olema Pharmaceuticals Announces Inducement Grants for New Employees Under 2022 Stock Option Plan

Reuters
·
Yesterday

Olema Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
01 Aug

Olema Pharmaceuticals Inc. Concluded Annual Stockholders Meeting

Reuters
·
14 Jun

BRIEF-Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
04 Jun

Promising Clinical Trial Results Justify Buy Rating for Olema Pharmaceuticals

TIPRANKS
·
02 Jun

Olema Pharmaceuticals: Strategic Dose Selection and Financial Projections Support Positive Outlook

TIPRANKS
·
28 May

Olema Pharmaceuticals Announces FDA Alignment on 90 mg Palazestrant Dose for Phase 3 Trials in Metastatic Breast Cancer

Reuters
·
28 May

Olema Pharmaceuticals Inc. to Participate in Jefferies Global Healthcare Conference in New York

Reuters
·
22 May

Olema Pharmaceuticals Is Maintained at Buy by Goldman Sachs

Dow Jones
·
14 May

Olema Pharmaceuticals: Promising Clinical Trials and Strategic Advancements Drive Buy Rating

TIPRANKS
·
14 May

Olema Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Olema Oncology Q1 Net Income USD -30.389 Million

Reuters
·
14 May

Olema Pharmaceuticals Q1 EPS $(0.36) Beats $(0.51) Estimate

Benzinga
·
14 May

Olema Pharmaceuticals Reports Q1 2025 Net Loss of $30.4M, Slightly Improved from $31.0M Loss in Q1 2024

Reuters
·
14 May

Press Release: Olema Oncology Reports First Quarter 2025 Financial and Operating Results

Dow Jones
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Olema Pharmaceuticals Inc. to Participate in H.C. Wainwright Annual BioConnect Investor Conference

Reuters
·
10 May

Top Premarket Decliners

MT Newswires Live
·
05 May

Olema Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview

Reuters
·
02 May

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Apr